Global Transdermal Patch Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Transdermal Patch Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Transdermal Patch Market Size Growth Rate by Type
  • 1.4.2 Methyl Salicylate-based Patch
  • 1.4.3 Rivastigmine Transdermal Patch
  • 1.2.4 Fentanyl Transdermal Patch
  • 1.2.5 Lidocaine Patch
  • 1.2.6 Diclofenac Patch
  • 1.2.7 Nicotine Transdermal Patch
  • 1.2.8 Others
• 1.3 Market by Application
  • 1.3.1 Global Transdermal Patch Market Size Growth Rate by Application
  • 1.3.2 Rx Channel
  • 1.3.3 OTC Channel
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Transdermal Patch Sales Estimates and Forecasts 2016-2027
• 2.2 Global Transdermal Patch Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Transdermal Patch Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Transdermal Patch Regions by Sales
  • 2.4.1 Global Top Transdermal Patch Regions by Sales (2016-2021)
  • 2.4.2 Global Top Transdermal Patch Regions by Sales (2022-2027)
• 2.5 Global Top Transdermal Patch Regions by Revenue
  • 2.5.1 Global Top Transdermal Patch Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Transdermal Patch Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Transdermal Patch Sales by Manufacturers
  • 3.1.1 Global Top Transdermal Patch Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Transdermal Patch Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Transdermal Patch Sales in 2020
• 3.2 Global Transdermal Patch Revenue by Manufacturers
  • 3.2.1 Global Top Transdermal Patch Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Transdermal Patch Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Transdermal Patch Revenue in 2020
• 3.3 Global Transdermal Patch Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Transdermal Patch Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Transdermal Patch Sales by Type
  • 4.1.1 Global Transdermal Patch Historical Sales by Type (2016-2021)
  • 4.1.2 Global Transdermal Patch Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Transdermal Patch Sales Market Share by Type (2016-2027)
• 4.2 Global Transdermal Patch Revenue by Type
  • 4.2.1 Global Transdermal Patch Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Transdermal Patch Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Transdermal Patch Revenue Market Share by Type (2016-2027)
• 4.3 Global Transdermal Patch Price by Type
  • 4.3.1 Global Transdermal Patch Price by Type (2016-2021)
  • 4.3.2 Global Transdermal Patch Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Transdermal Patch Sales by Application
  • 5.1.1 Global Transdermal Patch Historical Sales by Application (2016-2021)
  • 5.1.2 Global Transdermal Patch Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Transdermal Patch Sales Market Share by Application (2016-2027)
• 5.2 Global Transdermal Patch Revenue by Application
  • 5.2.1 Global Transdermal Patch Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Transdermal Patch Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Transdermal Patch Revenue Market Share by Application (2016-2027)
• 5.3 Global Transdermal Patch Price by Application
  • 5.3.1 Global Transdermal Patch Price by Application (2016-2021)
  • 5.3.2 Global Transdermal Patch Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Transdermal Patch Market Size by Type
  • 6.1.1 North America Transdermal Patch Sales by Type (2016-2027)
  • 6.1.2 North America Transdermal Patch Revenue by Type (2016-2027)
• 6.2 North America Transdermal Patch Market Size by Application
  • 6.2.1 North America Transdermal Patch Sales by Application (2016-2027)
  • 6.2.2 North America Transdermal Patch Revenue by Application (2016-2027)
• 6.3 North America Transdermal Patch Market Size by Country
  • 6.3.1 North America Transdermal Patch Sales by Country (2016-2027)
  • 6.3.2 North America Transdermal Patch Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Transdermal Patch Market Size by Type
  • 7.1.1 Europe Transdermal Patch Sales by Type (2017-2027)
  • 7.1.2 Europe Transdermal Patch Revenue by Type (2017-2027)
• 7.2 Europe Transdermal Patch Market Size by Application
  • 7.2.1 Europe Transdermal Patch Sales by Application (2017-2027)
  • 7.2.2 Europe Transdermal Patch Revenue by Application (2017-2027)
• 7.3 Europe Transdermal Patch Market Size by Country
  • 7.3.1 Europe Transdermal Patch Sales by Country (2017-2027)
  • 7.3.2 Europe Transdermal Patch Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Transdermal Patch Market Size by Type
  • 8.1.1 Asia Pacific Transdermal Patch Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Transdermal Patch Revenue by Type (2018-2027)
• 8.2 Asia Pacific Transdermal Patch Market Size by Application
  • 8.2.1 Asia Pacific Transdermal Patch Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Transdermal Patch Revenue by Application (2018-2027)
• 8.3 Asia Pacific Transdermal Patch Market Size by Region
  • 8.3.1 Asia Pacific Transdermal Patch Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Transdermal Patch Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Transdermal Patch Market Size by Type
  • 9.1.1 Latin America Transdermal Patch Sales by Type (2019-2027)
  • 9.1.2 Latin America Transdermal Patch Revenue by Type (2019-2027)
• 9.2 Latin America Transdermal Patch Market Size by Application
  • 9.2.1 Latin America Transdermal Patch Sales by Application (2019-2027)
  • 9.2.2 Latin America Transdermal Patch Revenue by Application (2019-2027)
• 9.3 Latin America Transdermal Patch Market Size by Country
  • 9.3.1 Latin America Transdermal Patch Sales by Country (2019-2027)
  • 9.3.2 Latin America Transdermal Patch Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Transdermal Patch Market Size by Type
  • 6.1.1 Middle East and Africa Transdermal Patch Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Transdermal Patch Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Transdermal Patch Market Size by Application
  • 6.2.1 Middle East and Africa Transdermal Patch Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Transdermal Patch Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Transdermal Patch Market Size by Country
  • 6.3.1 Middle East and Africa Transdermal Patch Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Transdermal Patch Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Hisamitsu Pharmaceutical
  • 11.1.1 Hisamitsu Pharmaceutical Corporation Information
  • 11.1.2 Hisamitsu Pharmaceutical Overview
  • 11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Description
  • 11.1.5 Hisamitsu Pharmaceutical Related Developments
• 11.2 Johnson & Johnson
  • 11.2.1 Johnson & Johnson Corporation Information
  • 11.2.2 Johnson & Johnson Overview
  • 11.2.3 Johnson & Johnson Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Johnson & Johnson Transdermal Patch Product Description
  • 11.2.5 Johnson & Johnson Related Developments
• 11.3 Novartis
  • 11.3.1 Novartis Corporation Information
  • 11.3.2 Novartis Overview
  • 11.3.3 Novartis Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Novartis Transdermal Patch Product Description
  • 11.3.5 Novartis Related Developments
• 11.4 UCB Pharma
  • 11.4.1 UCB Pharma Corporation Information
  • 11.4.2 UCB Pharma Overview
  • 11.4.3 UCB Pharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 UCB Pharma Transdermal Patch Product Description
  • 11.4.5 UCB Pharma Related Developments
• 11.5 Mylan
  • 11.5.1 Mylan Corporation Information
  • 11.5.2 Mylan Overview
  • 11.5.3 Mylan Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Mylan Transdermal Patch Product Description
  • 11.5.5 Mylan Related Developments
• 11.6 Teva Pharmaceutical
  • 11.6.1 Teva Pharmaceutical Corporation Information
  • 11.6.2 Teva Pharmaceutical Overview
  • 11.6.3 Teva Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Teva Pharmaceutical Transdermal Patch Product Description
  • 11.6.5 Teva Pharmaceutical Related Developments
• 11.7 Nitto Denko
  • 11.7.1 Nitto Denko Corporation Information
  • 11.7.2 Nitto Denko Overview
  • 11.7.3 Nitto Denko Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Nitto Denko Transdermal Patch Product Description
  • 11.7.5 Nitto Denko Related Developments
• 11.8 Grünenthal
  • 11.8.1 Grünenthal Corporation Information
  • 11.8.2 Grünenthal Overview
  • 11.8.3 Grünenthal Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Grünenthal Transdermal Patch Product Description
  • 11.8.5 Grünenthal Related Developments
• 11.9 IBSA Group
  • 11.9.1 IBSA Group Corporation Information
  • 11.9.2 IBSA Group Overview
  • 11.9.3 IBSA Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 IBSA Group Transdermal Patch Product Description
  • 11.9.5 IBSA Group Related Developments
• 11.10 GSK
  • 11.10.1 GSK Corporation Information
  • 11.10.2 GSK Overview
  • 11.10.3 GSK Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 GSK Transdermal Patch Product Description
  • 11.10.5 GSK Related Developments
• 11.1 Hisamitsu Pharmaceutical
  • 11.1.1 Hisamitsu Pharmaceutical Corporation Information
  • 11.1.2 Hisamitsu Pharmaceutical Overview
  • 11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Description
  • 11.1.5 Hisamitsu Pharmaceutical Related Developments
• 11.12 Pfizer
  • 11.12.1 Pfizer Corporation Information
  • 11.12.2 Pfizer Overview
  • 11.12.3 Pfizer Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Pfizer Product Description
  • 11.12.5 Pfizer Related Developments
• 11.13 Chattem
  • 11.13.1 Chattem Corporation Information
  • 11.13.2 Chattem Overview
  • 11.13.3 Chattem Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Chattem Product Description
  • 11.13.5 Chattem Related Developments
• 11.14 Dr Reddy’s Laboratories
  • 11.14.1 Dr Reddy’s Laboratories Corporation Information
  • 11.14.2 Dr Reddy’s Laboratories Overview
  • 11.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Dr Reddy’s Laboratories Product Description
  • 11.14.5 Dr Reddy’s Laboratories Related Developments
• 11.15 Bayer
  • 11.15.1 Bayer Corporation Information
  • 11.15.2 Bayer Overview
  • 11.15.3 Bayer Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Bayer Product Description
  • 11.15.5 Bayer Related Developments
• 11.16 Mundipharma
  • 11.16.1 Mundipharma Corporation Information
  • 11.16.2 Mundipharma Overview
  • 11.16.3 Mundipharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Mundipharma Product Description
  • 11.16.5 Mundipharma Related Developments
• 11.17 Endo International
  • 11.17.1 Endo International Corporation Information
  • 11.17.2 Endo International Overview
  • 11.17.3 Endo International Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 Endo International Product Description
  • 11.17.5 Endo International Related Developments
• 11.18 Beijing Tide Pharmaceutical
  • 11.18.1 Beijing Tide Pharmaceutical Corporation Information
  • 11.18.2 Beijing Tide Pharmaceutical Overview
  • 11.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.18.4 Beijing Tide Pharmaceutical Product Description
  • 11.18.5 Beijing Tide Pharmaceutical Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Transdermal Patch Value Chain Analysis
• 12.2 Transdermal Patch Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Transdermal Patch Production Mode & Process
• 12.4 Transdermal Patch Sales and Marketing
  • 12.4.1 Transdermal Patch Sales Channels
  • 12.4.2 Transdermal Patch Distributors
• 12.5 Transdermal Patch Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Transdermal Patch Industry Trends
• 13.2 Transdermal Patch Market Drivers
• 13.3 Transdermal Patch Market Challenges
• 13.4 Transdermal Patch Market Restraints

14 Key Findings in The Global Transdermal Patch Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details